Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized Controlled Comparison of Effect of Evolocumab Versus Standard Lipid Lowering Therapy on Plaque Progression in Patients With Acute Coronary Syndrome by Serial PCCT (CAPRA-EVO Trial)

NCT07612774 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07612774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07612774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized Controlled Comparison of Effect of Evolocumab Versus Standard Lipid Lowering Therapy on Plaque Progression in Patients With Acute Coronary Syndrome by Serial PCCT (CAPRA-EVO Trial)
Lead sponsor
West China Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
November 19, 2025
Completion date
December 31, 2029
Enrollment
232 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary, coronary artery disease